deltaDOT analytical technology is based on an innovative approach to Capillary Electrophoresis (CE). Patented multipoint sensor system together with the proprietary computing algorithms give superior resolution, accuracy and repeatability. This is High Performance Capillary Electrophoresis (HPCE) at its best - Label Free Intrinsic Imaging (LFII™), this technology has found successful applications in detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and bacteria, drugs, chemicals and a wide range of other analytes.
deltaDOT Label Free technology allows the direct monitoring of unlabelled biomolecules offering faster and higher quality results at a fraction of the cost of conventional approaches.
deltaDOT received new investment in May 2010 as a part of the Company's financial and management restructuring. The Company is poised for a significant drive in the market exploitation of their unique technology. In addition to previous sales and applications of the Peregrine machines, a number of major international players and government organizations have successfully evaluated deltaDOT LFII™ technology for their specific applications.
Apart from the sales of machines deltaDOT is actively seeking and is in discussions with major players in Life Sciences industry and with defence contractors to license its patented technology for OEM labelled products.